Hepatitis C Information Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatments here at Hepatitis-Central.com.

Hep C information
Free Newsletter
Hepatitis C Newsletter
We value your privacy. We will not rent your email to anyone.
HEPATITIS NEWS
The top stories compiled from over 5,500 sources, updated every 15 minutes

Interferon as Long-Term Treatment for Hepatitis C Not Effective
Newswise Use of the drug interferon as a long-term maintenance strategy to slow the progression of liver disease associated with the hepatitis C virus is ineffective, researchers and their colleagues from nine other institutions have found in a

Delhi schoolkids made aware of hepatitis, organ donation
New Delhi (IANS): School children of Delhi were Thursday made aware of measures to combat dreaded liver disease, hepatitis, as well as the importance of organ donation in saving the lives of persons afflicted by it. Over 100 students attended the

Hepatitis C therapy useless for some
WEDNESDAY, Dec. 3 (HealthDay News) -- Maintenance therapy using low-dose peginterferon doesn't help patients with advanced chronic hepatitis C who haven't responded to an initial round of treatment, new research suggests. The study also showed a

UPDATES AND COMMENTARY RSS Feed

Hep C Study Reveals Taribavirin a Good Alternative to Ribavirin
At the end of a 48-week, Phase IIb study, taribavirin shows similar effectiveness as ribavirin in reducing Hepatitis C viral load. However, participants taking taribavirin had a significantly lower rate of anemia....

Schering-Plough Developing Potent Protease Inhibitor for Hepatitis C
An ongoing Phase IIa study on Schering-Plough's next generation Hepatitis C protease inhibitor is encouraging. According to the company, SCH 900518 is 10 times more potent than other medications in this class and is active against highly resistant Hepatitis C...

New Drug Finds Viral Hiding Spots
A new, experimental drug helps the immune system locate a virus by flagging cells that have turned inside out. Hepatitis C is among the viruses that could benefit from Bavituximab's unique strategy of exposing a virus in hiding....

J Hepatol 1997 Dec;27(6):1110-1112

Acute hepatitis caused by sexual or household transmission of GBV-C.

Tanaka T, Takeuchi T, Inoue K, Tanaka S, Kohara M Liver Unit, The Tokyo Metropolitan Komagome Hospital, Japan.

BACKGROUND/AIMS:

Transfusion transmission is the only known transmission route of the recently identified GBV-C. To date, no evidence of household transmission of GBV-C has been reported. In the present study, a case of acute GBV-C hepatitis was investigated with respect to the mode of transmission.

METHODS:

A 24-year-old woman with acute GBV-C hepatitis and her asymptomatic husband were examined. Two GBV-C RNA samples, isolated at different times from both the patient and her husband were amplified by reverse transcriptase-polymerase chain reaction using sequences from the NS3 region. Sequencing of this region was subsequently performed for all four samples.

RESULTS/CONCLUSIONS:

The genomic RNA sequences of GBV-C isolated from each partner at two different time points were found to be 100% homologous. However, these genomic GBV-C RNA sequences differed in the NS3 (helicase) region from the genomic RNA isolated from the GBV-C prototype previously reported by Simons et al. Nonetheless, high homology (83%) was found between the GBV-C prototype and the GBV-C isolated from our patients. In addition, four nucleotides of the GBV-C RNA in the present study are unique and are not present in any other reported sequences of GBV-C. These results strongly suggest that GBV-C is one of the etiological agents involved in severe liver injury and was transmitted between this couple.

PMID: 9453438, UI: 98114183

  Hep C information

Information at this website is for educational purposes only; statements about products and health conditions
have not been evaluated by the U.S. Food & Drug Administration.

©1994-2008 Hepatitis-Central.com
Updated 05 Dec 2008